cervical adenocarcinoma

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Recurrent Cervical Carcinoma Trial in United States (Laboratory

Active, not recruiting
  • Cervical Adenocarcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Birmingham, Alabama
  • +336 more
Jan 28, 2023

Primary Cervical Cancer Screening by Self-sampling HPV Test

Recruiting
  • Human Papillomavirus Infection
  • +16 more
    • Beijing, Beijing, China
    • +5 more
    Jan 12, 2023

    Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

    Recruiting
    • Cervical Adenocarcinoma
    • +47 more
    • Bevacizumab
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Dec 5, 2022

    MRI and PET Imaging in Predicting Treatment Response in Stage

    Active, not recruiting
    • Cervical Adenocarcinoma
    • +12 more
    • Computed Tomography
    • +5 more
    • Miami, Florida
    • +5 more
    Oct 4, 2022

    Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

    Recruiting
    • Acinar Cell Carcinoma
    • +93 more
    • Biospecimen Collection
    • +2 more
    • Birmingham, Alabama
    • +998 more
    Aug 23, 2022

    Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma Trial in

    Recruiting
    • Advanced Vaginal Adenocarcinoma
    • +20 more
    • Brachytherapy
    • +6 more
    • Birmingham, Alabama
    • +383 more
    Aug 18, 2022

    Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

    Recruiting
    • Cervical Adenocarcinoma
    • +11 more
    • Media Intervention
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

    Withdrawn
    • Cervical Adenocarcinoma
    • +6 more
    • Cape Town, South Africa
    • +2 more
    Jun 14, 2022

    Clinical Evaluation of Detection of High Risk HPV in Urine

    Recruiting
    • Human Papillomavirus Infection
    • +17 more
      • Beijing, Beijing, China
      • +2 more
      Jan 21, 2022

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Completed
      • Cervical Adenocarcinoma
      • +6 more
      • Los Angeles, California
      • +21 more
      Apr 20, 2021

      Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen

      Recruiting
      • Cervical Adenocarcinoma
      • +54 more
      • Biospecimen Collection
      • Laboratory Biomarker Analysis
      • Houston, Texas
      • +1 more
      Nov 30, 2020

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Completed
      • Cervical Adenocarcinoma
      • +3 more
      • Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001
      • Laboratory Biomarker Analysis
      • Birmingham, Alabama
      • +23 more
      Aug 21, 2020

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Completed
      • Cervical Adenocarcinoma
      • +8 more
      • Los Angeles, California
      • +15 more
      Sep 1, 2020

      Cervical Adenocarcinoma, Stage IB Cervical Cancer, Stage II Cervical Cancer Trial in France (External Beam Radiation Therapy,

      Completed
      • Cervical Adenocarcinoma
      • +3 more
      • External Beam Radiation Therapy
      • +2 more
      • Besancon, France
      • +8 more
      Mar 6, 2020

      Cervical Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial run by the NCI (Ixempra (Ixabepilone

      Terminated
      • Cervical Carcinoma
      • +3 more
      • Ixempra (Ixabepilone (BMS-247550) )
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 13, 2019

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (biological,

      Completed
      • Cervical Adenocarcinoma
      • +7 more
      • Filgrastim
      • +4 more
      • Orange, California
      • +77 more
      Aug 6, 2019

      Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma Trial in Worldwide (radiation,

      Completed
      • Cervical Adenocarcinoma
      • +13 more
      • fludeoxyglucose F 18
      • +6 more
      • Los Angeles, California
      • +32 more
      Jul 19, 2019

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Completed
      • Cervical Adenocarcinoma
      • +4 more
      • Los Angeles, California
      • +24 more
      Jul 17, 2019

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Completed
      • Cervical Adenocarcinoma
      • +4 more
      • Brivanib Alaninate
      • Laboratory Biomarker Analysis
      • Phoenix, Arizona
      • +42 more
      Mar 8, 2019

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Unknown status
      • Cervical Adenocarcinoma
      • +8 more
      • Orange, California
      • +13 more
      Mar 8, 2019

      Effects of Immunotherapy, Metastatic/Recurrent Cervical Cancer, Cervical Adenocarcinoma Trial in United States (ADXS11-001)

      Completed
      • Effects of Immunotherapy
      • +8 more
      • ADXS11-001
      • Miami, Florida
      • +3 more
      Mar 4, 2019

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (Paclitaxel

      Completed
      • Cervical Adenocarcinoma
      • +4 more
      • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
      • Laboratory Biomarker Analysis
      • Aurora, Colorado
      • +25 more
      Dec 17, 2018

      HPV Integration and Tumorigenesis of Uterine Cervical

      Unknown status
      • Cervical Adenocarcinoma
      • +7 more
      • A multi-omics analysis
      • Beijing, Beijing, China
        Lei Li
      Nov 13, 2018

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma Trial in Philadelphia (Cisplatin,

      Completed
      • Cervical Adenocarcinoma
      • +4 more
      • Philadelphia, Pennsylvania
        Gynecologic Oncology Group
      Sep 18, 2018